SCHEMBL312899

SCHEMBL312899

CC(C)(C)OC(=O)N1CCC(Nc2ccc3sc(C(N)=O)cc3c2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
MAPT P10636 1/20 0.55
MAPK1 P28482 1/20 0.55
HTT P42858 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
ACKR3 P25106 1/20 0.47
DYRK1A Q13627 1/20 0.46
GPR119 Q8TDV5 3/20 0.45
PTPN2 P17706 1/20 0.45
PTPN1 P18031 1/20 0.45
PTPN6 P29350 1/20 0.45
CCNA2 P20248 1/20 0.45
CDK2 P24941 1/20 0.45
DDB1 Q16531 1/20 0.44
CRBN Q96SW2 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL312838 0.81 ALDH1A1 (0.60) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL6154407 0.78 ALDH1A1 (0.72) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL6155117 0.77 ALDH1A1 (0.62) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL6154643 0.77 ALDH1A1 (0.60) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL6155198 0.77 ALDH1A1 (0.60) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL13158349 0.77 ALDH1A1 (0.60) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL13159519 0.77 ALDH1A1 (0.65) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL10210061 0.77 ALDH1A1 (0.79) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL6154127 0.76 ALDH1A1 (0.65) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL1704497 0.76 ALDH1A1 (0.68) ALDH1A1NPC1RAB9AMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093285-B2 Aminopiperidinyl derivatives and uses thereof ROCHE PALO ALTO LLC (US) 2012-01-10 US disclosed
US-20090247568-A1 AMINOPIPERIDINYL DERIVATIVES AND USES THEREOF ROCHE PALO ALTO LLC 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247568-A1 AMINOPIPERIDINYL DERIVATIVES AND USES THEREOF MAOB, ADORA2B, HTR1B ALDH1A1 524/4885NPC1 2989/4885RAB9A 200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.